Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.Nature Medicine|April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P Casazza, Evan M Cale, Sandeep Narpala, et al.Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.Science Immunology|February 13, 2026
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV V2 apex broadly neutralizing antibody developmentRumi Habib, Ryan S Roark, Hui Li, et al.Cell|May 21, 2021
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodiesWilton B Williams, R Ryan Meyerhoff, R J Edwards, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody developmentRumi Habib, Ryan S Roark, Hui Li, et al.Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Induction of multiple HIV-1 neutralizing B Cell Precursors in HumansChen-Hao Yeh, Stephen R Walsh, Ruth Parsons, et al.Nature|July 1, 2026
Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodiesLorie Marchitto, Kshitij Wagh, Ryan S Roark, et al.Science (New York, N.Y.)|November 20, 2020
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadthRyan S Roark, Hui Li, Wilton B Williams, et al.Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.Pageof 15